Supriya Lifescience appoints Dr. Shekhar Bhirud as President – Business Development, Strategy and R&D

Supriya Lifescience Ltd. a cGMP compliant company having a well established presence in API Manufacturing with focus in products of various therapeutic segments like – Anti-Histamine, Anti-Allergics, Vitamins, Anaesthetics, AntiAsthmatics etc. has announced appointment of Dr. Shekhar Bhirud as President – Business Development, Strategy and R&D.

Dr. Shekhar Bhirud has over 34+ years of rich functional experience in the manufacturing domain of Bulk Drugs, Business development of API’s, API R&D function with strategic planning to convert the unit into profit centeric mindset, a statement said.

Dr Bhirud is a Ph.D (Chem) holder from Mumbai University, Maharashtra in 1988. He also holds M.Sc (Chem) & B.Sc (Chem) with first class. Dr. Bhirud played a vital role in process development, optimization, and commissioning of the various plants across multiple companies. His close collaboration with international scientists and his responsibility for standardizing production and quality control earned him recognition at workplaces. During his long span of career he has consistently displayed a passion for innovation and has made significant contributions to the field. With an impressive record of 73 process patents and several scientific publications to his credit, he has showcased his ability to drive research and development initiatives, the statement said.

Throughout his career, he has maintained an impeccable record with reputable companies like Cipla Ltd, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd., DAI-ICHI Karkaria Ltd, Akums Drugs & Pharmaceutical Ltd Ind Swift Labs, Farmaprojects S.A, Glaxo Ltd, Etc., according to the statement.

He has strategic leadership attributes with a strong business acumen and a track record of delivering exceptional results. His extensive experience in diverse areas of the pharmaceutical industry, combined with his strategic thinking and innovation-driven mindset, make him a valuable asset to any organization, the statement said.

Commenting on the appointment, Dr. Satish Wagh, Chairman & Managing Director, stated “Mr. Bhirud’s exceptional expertise and extensive experience in the pharmaceutical industry, we are confident that he is the perfect leader for our organization. His remarkable background in the pharma sector, coupled with his hands-on approach, will greatly contribute to strengthening our manufacturing excellence and driving strategic alliances.”

Dr. Shekhar Bhirud, stated “I am thrilled to become a part of the dynamic Supriya team. Supriya’s exceptional business model and talented management team create a unique advantage for us to seize opportunities in the evolving pharmaceutical landscape. I firmly believe that Supriya is well-positioned to achieve new milestones through strategic initiatives.”

+ posts

HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.

What's your take on this post ? Comment: